United States

Cummings criticizes Turing’s fake price cut

Friday, December 4, 2015

Rep. Elijah Cummings (D-Md.), ranking member of the House Committee on Oversight and Government Reform, has sent a letter to former hedge fund manager Martin Shkreli, CEO of Turing Pharmaceuticals, condemning his company’s efforts to tout a 50% “price cut” for Daraprim after the company increased the price of the drug in August by 5,000%.

[Read More]

Baxalta opens Global Innovation Center

Friday, December 4, 2015

Baxalta, a global biopharmaceutical provider dedicated to delivering transformative therapies to patients with orphan diseases and underserved conditions, has announced the official opening of its Global Innovation Center in Cambridge, Mass.

[Read More]